“Intravenous administration of patisiran-LC (0, 0.3, 1, or 2 mg/kg) to adult monkeys every three weeks for 39 weeks produced no adverse effects on male reproductive organs or on sperm morphology or count.”
“IV infusion was used in the repeat-dose toxicology studies with in general a once every two- or three-week dosing interval to support the clinical route and timing of dose administration.”